A Research Study on How Well Concizumab Works for You if You Have Haemophilia A or B With or Without Inhibitors

Recruiting

Phase 3

ConcizumabA Research Study on How Well Concizumab Works for You if You Have Haemophilia A or B With or Without Inhibitors

Sponsor:

Novo Nordisk A/S

Code:

NCT05135559

Conditions

Haemophilia A and B With and Without Inhibitors

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Concizumab

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-01. This information was provided to ClinicalTrials.gov by Novo Nordisk A/S on 2025-05-28.